Board Committee Changes
GlaxoSmithKline plc today announces the following change to its Board Committee membership effective 23 July 2021.
Dr Anne Beal has been appointed a member of the Audit & Risk Committee. This appointment is in addition to her membership of the Corporate Responsibility Committee.
V A Whyte
Company Secretary
23 July 2021

Attachments

  • Original document
  • Permalink

Disclaimer

GSK - GlaxoSmithKline plc published this content on 23 July 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 23 July 2021 14:47:11 UTC.